R&D Simplification, standardisation & AI-enabled industry: Veeva... Focused on innovating together, and together advancing industry, the Veeva R&D Summit this year highlighted an intention on one, AI-enabled cloud.
News Third time lucky for Replimune as FDA OKs melanoma drug At its third attempt, Replimune has finally won FDA approval for its advanced melanoma treatment RP1, now named Tudriqev and its first product.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.